An Act To Correct Inconsistencies, Conflicts and Errors in the Laws of Maine
Maine Legislature, Session 129, LD 2169
Committee: Judiciary
Amends: 4 MRSA §1051, 5 MRSA §1531, 5 MRSA §1710-D, 5 MRSA §1710-I, 5 MRSA §3101, 5 MRSA §3102, 5 MRSA §3103, 5 MRSA §12004-C, 5 MRSA §13056, 9-A MRSA §14, 10 MRSA §363, 20-A MRSA §7406, 10 MRSA §1310-H, 10 MRSA §9722, 12 MRSA §8876, 12 MRSA §11154, 19-A MRSA §4012, 20-A MRSA §10, 22 MRSA §2422, 22 MRSA §2428, 22 MRSA §3739, 24-A MRSA §4316, 25 MRSA §1542-A, 26 MRSA §3, 30-A MRSA §4312, 30-A MRSA §5903, 35-A MRSA §3454, 35-A MRSA §10104, 35-A MRSA §10110, 36 MRSA §1754-B, 36 MRSA §1817, 37-B MRSA §111, 38 MRSA §484

Legislative Document
No. 2169
H.P. 1552
House of Representatives, July 28, 2020
An Act To Correct Inconsistencies, Conflicts and Errors in the Laws 
of Maine
(EMERGENCY)
Reported by Representative BAILEY of Saco for the Revisor of Statutes pursuant to the 
Maine Revised Statutes, Title 1, section 94.
Received by the Clerk of the House on July 28, 2020.  Referred to the Committee on 
Judiciary pursuant to Joint Rule 308.2 and ordered printed.
ROBERT B. HUNT
Clerk
Emergency preamble. Whereas, acts and resolves of the Legislature do not 
become effective until 90 days after adjournment unless enacted as emergencies; and 
Whereas, acts of this and previous Legislatures have resulted in certain technical 
inconsistencies, conflicts and errors in the laws of Maine; and 
Whereas, these inconsistencies, conflicts and errors create uncertainties and 
confusion in interpreting legislative intent; and 
Whereas, it is vitally necessary that these uncertainties and this confusion be 
resolved in order to prevent any injustice or hardship to the citizens of Maine; and 
Whereas, in the judgment of the Legislature, these facts create an emergency within 
the meaning of the Constitution of Maine and require the following legislation as 
immediately necessary for the preservation of the public peace, health and safety; now, 
therefore, 
Be it enacted by the People of the State of Maine as follows: 
Sec. 1.  4 MRSA §1051, as amended by PL 2019, c. 59, §1 and c. 475, §49, is 
repealed and the following enacted in its place: 
§1051.  Legal holidays 
Court may not be held on Sunday or any day designated for the annual Thanksgiving; 
New Year's Day, January 1st; Martin Luther King, Jr., Day, the 3rd Monday in January; 
Washington's Birthday, the 3rd Monday in February; Patriot's Day, the 3rd Monday in 
April; Memorial Day, the last Monday in May, but if the Federal Government designates 
May 30th as the date for observance of Memorial Day, the 30th of May; the 4th of July; 
Labor Day, the first Monday of September; Indigenous Peoples Day, the 2nd Monday in 
October; Veterans Day, November 11th; or on Christmas Day.  The Chief Justice of the 
Supreme Judicial Court may order that court be held on a legal holiday when the Chief 
Justice finds that the interests of justice and judicial economy in any particular case will 
be served.  The public offices in county buildings may be closed to business on the 
holidays named in this section.  When any one of the holidays named in this section falls 
on Sunday, the Monday following must be observed as a holiday, with all the privileges 
applying to any of the days named in this section. 
Sec. 2.  5 MRSA §1531, sub-§2, as amended by PL 2019, c. 343, Pt. D, §2 and Pt. 
IIII, §1, is repealed and the following enacted in its place: 
2.  Average personal income growth.  "Average personal income growth" means 
the average for the prior 10 calendar years, ending with the most recent calendar year for 
which data is available, of the percent change in personal income in this State, as 
estimated by the United States Department of Commerce, Bureau of Economic Analysis.  
The average personal income growth is determined by October 1st, annually, by the State 
Economist. 
Sec. 3.  5 MRSA §1710-D, as amended by PL 2019, c. 343, Pt. D, §4 and Pt. IIII, 
§2, is repealed and the following enacted in its place: 
§1710-D.  Staffing 
The commission may receive staff support from the Department of Administrative 
and Financial Services and the Department of Labor. 
Sec. 4.  5 MRSA §1710-I, as amended by PL 2019, c. 343, Pt. D, §5 and Pt. IIII, 
§3, is repealed and the following enacted in its place: 
§1710-I.  Staffing 
The committee may receive staff assistance from the Department of Administrative 
and Financial Services and, at the discretion of the Legislature, the Office of Fiscal and 
Program Review.  The committee may also utilize other professionals having revenue 
forecasting, economic and fiscal expertise. 
Sec. 5.  5 MRSA c. 167, as enacted by PL 2019, c. 471, §1 and c. 472, §1, is 
repealed and the following enacted in its place: 
CHAPTER 167 
MAINE PRESCRIPTION DRUG AFFORDABILITY BOARD 
§2041.  Maine Prescription Drug Affordability Board established 
1.  Board established.  The Maine Prescription Drug Affordability Board, as 
established in section 12004-G, subsection 14-I and referred to in this chapter as "the 
board," shall carry out the purposes of this chapter. 
2.  Membership.  The board has 5 members with expertise in health care economics 
or clinical medicine, who may not be affiliated with or represent the interests of a public 
payor, as that term is defined in section 2042, and who are appointed as follows: 
A.  Two members by the President of the Senate.  The President of the Senate shall 
also appoint one alternate board member who will participate in deliberations of the 
board in the event a member appointed by the President of the Senate elects to be 
recused as provided in subsection 7, paragraph B; 
B.  Two members by the Speaker of the House of Representatives.  The Speaker of 
the House of Representatives shall also appoint one alternate board member who will 
participate in deliberations of the board in the event a member appointed by the 
Speaker of the House of Representatives elects to be recused as provided in 
subsection 7, paragraph B; and 
C.  One member by the Governor.  The Governor shall also appoint one alternate 
board member who will participate in deliberations of the board in the event the 
member appointed by the Governor elects to be recused as provided in subsection 7, 
paragraph B. 
3.  Terms.  Members are appointed to 5-year terms.  Of the initial appointees, the 
member appointed by the Governor serves an initial term of 5 years, one member 
appointed by the President of the Senate and one member appointed by the Speaker of the 
House of Representatives serve an initial term of 4 years and one member appointed by 
the President of the Senate and one member appointed by the Speaker of the House of 
Representatives serve an initial term of 3 years. 
4.  Quorum.  A majority of board members constitutes a quorum. 
5.  Chair.  The Governor shall name the chair. 
6.  Meetings.  Beginning no later than March 1, 2020, the board shall meet in public 
session at least every 12 weeks to review prescription drug information and to make 
recommendations pursuant to section 2042.  Meetings may be cancelled or postponed at 
the discretion of the chair. 
A.  Each public meeting must be announced 2 weeks in advance, and materials for 
the meeting must be made public at least one week in advance. 
B.  Each public meeting must provide opportunity for comment from the public in 
attendance at the meeting, and the board shall provide the opportunity for the public 
to submit written comments on pending decisions. 
C.  The board may allow expert testimony at public meetings and any meeting 
conducted in executive session as permitted by paragraph D. 
D.  Notwithstanding the requirements of Title 1, section 405, the board may meet in 
executive session, except that any decision of the board must be made in public. 
7.  Conflicts of interest.  The following provisions govern any conflict of interest for 
a member of the board, a member of the advisory council established pursuant to 
subsection 10 or any staff member or contractor of the board. 
A.  When appointing a member of the board or the advisory council established 
pursuant to subsection 10, the appointing authority shall consider any conflict of 
interest disclosed by the prospective member.  A member shall elect to be recused 
from any board activity in the case in which the member or an immediate family 
member of the member has a conflict of interest.  For the purposes of this paragraph, 
"conflict of interest" means an association, including a financial or personal 
association, that has the potential to bias or have the appearance of biasing an 
individual's decisions in matters related to the board or the conduct of the board's 
activities. 
B.  A board member or staff or contractor of the board with a conflict of interest shall 
elect to be recused.  For purposes of this paragraph, "conflict of interest" means any 
instance in which a member of the board or an immediate family member of the 
member has received or could receive either of the following: 
(1)  A direct financial benefit of any amount deriving from the results or findings 
of a study or determination by or for the board; or 
(2)  A financial benefit from individuals or companies that own or manufacture 
prescription drugs, services or items to be studied by the board that in the 
aggregate exceeds $5,000 per year.  For purposes of this subparagraph, "financial 
benefit" includes honoraria, fees, stock or other financial benefit and the current 
value of the member's or immediate family member's already existing stock 
holdings, in addition to any direct financial benefit deriving from the results or 
findings conducted under this section. 
C.  A conflict of interest must be disclosed in the following manner: 
(1)  By the board in the employment of board senior staff; 
(2)  By the Governor, President of the Senate or Speaker of the House of 
Representatives when appointing members to the board and advisory council 
established pursuant to subsection 10; 
(3)  By the board, describing any recusals as part of any final decision relating to 
a prescription drug; and 
(4)  By the 5th day after a conflict is identified or, if a public meeting of the 
board will occur within that 5-day period, in advance of the public meeting. 
D.  Conflicts of interest must be publicly posted on the website of the board.  The 
information disclosed must include the type, nature and magnitude of the interests of 
the individual involved, except to the extent that the individual elects to be recused 
from participation in any activity with respect to which the potential conflict exists. 
E.  The board, the advisory council established pursuant to subsection 10, a member 
of the board or staff or a contractor of the board may not accept gifts, bequests or 
donations of services or property that suggest a conflict of interest or have the 
appearance of creating bias in the work of the board or advisory council. 
F.  A member of the advisory council established pursuant to subsection 10 who 
accepts a gift, bequest or donation of services or property that suggests a conflict of 
interest or has the appearance of creating bias in the work of the advisory council 
shall disclose the gift, bequest or donation publicly. 
8.  Staff.  The board may employ an executive director, whose salary, to the extent 
feasible, must comport with state personnel rules and requirements. 
9.  Compensation.  A member of the board and a member of the advisory council 
appointed pursuant to subsection 10, paragraph L are entitled to legislative per diem and 
reimbursement for expenses as provided in section 12004-G, subsection 14-I. 
10.  Advisory council.  A 12-member advisory council is established to advise the 
board on establishing annual spending targets pursuant to section 2042, subsection 1 and 
determining methods for meeting those spending targets pursuant to section 2042, 
subsection 3.  The advisory council consists of: 
A.  The Governor or the Governor's designee; 
B.  The Commissioner of Administrative and Financial Services or the 
commissioner's designee; 
C.  The Commissioner of Corrections or the commissioner's designee; 
D.  The Commissioner of Health and Human Services or the commissioner's 
designee; 
E.  The Attorney General or the Attorney General's designee; 
F.  The Executive Director of Employee Health and Benefits, within the Department 
of Administrative and Financial Services, Bureau of Human Resources, or the 
executive director's designee; 
G.  A representative from the Maine State Employees Association, appointed by the 
Governor, based on a nomination by the association; 
H.  A representative from the Maine Education Association, appointed by the 
Governor, based on a nomination by the association; 
I.  A representative from the Maine Municipal Association, appointed by the 
Governor, based on a nomination by the association; 
J.  A representative from the University of Maine System, appointed by the 
Governor, based on a nomination by the system; 
K.  A representative from the Maine Community College System, appointed by the 
Governor, based on a nomination by the system; and 
L.  A representative of consumer interests, appointed by the Governor, who serves a 
3-year term. 
11.  Funds and grants.  The board may apply for and receive funds, grants or 
contracts from public and private sources. 
12.  Assessment.  The board may recommend that a public payor, as defined in 
section 2042, subsection 1, pay an annual assessment to support the administrative costs 
of the board. 
§2042.  Powers and duties of the board 
1.  Prescription drug spending targets.  The board has the following powers and 
duties.  For the purposes of this section, the term "public payor" means any division of 
state, county or municipal government that administers a health plan for employees of 
that division of state, county or municipal government or an association of state, county 
or municipal employers that administers a health plan for its employees, except for the 
MaineCare program.  The board shall: 
A.  Beginning for the year 2021 and in consultation with the advisory council 
established under section 2041, subsection 10, determine annual spending targets for 
prescription drugs purchased by public payors based upon a 10-year rolling average 
of the medical care services component of the United States Department of Labor, 
Bureau of Labor Statistics Consumer Price Index medical care services index plus a 
reasonable percentage for inflation and minus a spending target determined by the 
board for pharmacy savings; 
B.  Determine spending targets on specific prescription drugs that may cause 
affordability challenges to enrollees in a public payor health plan; and 
C.  Determine which public payors are likely to exceed the spending targets 
determined under paragraph A. 
2.  Prescription drug spending data.  The board may consider the following data to 
accomplish its duties under this section: 
A.  A public payor's prescription drug spending data, which the 3rd-party 
administrator or insurer for the public payor's health plan shall provide to the board 
on behalf of the public payor upon request notwithstanding any provision of law to 
the contrary, including: 
(1)  Expenditures and utilization data for prescription drugs for each plan offered 
by a public payor; 
(2)  The formulary for each plan offered by a public payor and prescription drugs 
common to each formulary; 
(3)  Pharmacy benefit management services and other administrative expenses of 
the prescription drug benefit for each plan offered by a public payor; and 
(4)  Enrollee cost sharing for each plan offered by a public payor; and 
B.  Data compiled by the Maine Health Data Organization under Title 22, chapter 
1683. 
Prescription drug spending data provided to the board under this subsection is 
confidential to the same extent it is confidential while in the custody of the entity that 
provided the data to the board. 
3.  Recommendations.  Based upon the prescription drug spending data received 
under subsection 2, the board, in consultation with a representative of each public payor 
identified under subsection 1, paragraph A, shall determine methods for the public payor 
to meet the spending targets established under subsection 1. The board shall determine 
whether the following methods reduce costs to individuals purchasing prescription drugs 
through a public payor and allow public payors to meet the spending targets established 
under subsection 1: 
A.  Negotiating specific rebate amounts on the prescription drugs that contribute most 
to spending that exceeds the spending targets; 
B.  Changing a formulary when sufficient rebates cannot be secured under paragraph 
A; 
C.  Changing a formulary with respect to all of the prescription drugs of a 
manufacturer within a formulary when sufficient rebates cannot be secured under 
paragraph A; 
D.  Establishing a common prescription drug formulary for all public payors; 
E.  Prohibiting health insurance carriers in the State from offering on their 
formularies a prescription drug or any of the prescription drugs manufactured by a 
particular manufacturer when the methods described in paragraph B or C are 
implemented; 
F.  Purchasing prescription drugs in bulk or through a single purchasing agreement 
for use among public payors; 
G.  Collaborating with other states and state prescription drug purchasing consortia to 
purchase prescription drugs in bulk or to jointly negotiate rebates; 
H.  Allowing health insurance carriers providing coverage to small businesses and 
individuals in the State to participate in the public payor prescription drug benefit for 
a fee; 
I.  Procuring common expert services for public payors, including but not limited to 
pharmacy benefit management services and actuarial services; and 
J.  Any other method the board may determine. 
4.  Report.  The board shall report its recommendations, including prescription drug 
spending targets, and the progress of implementing those recommendations to the joint 
standing committee of the Legislature having jurisdiction over health coverage and 
insurance matters no later than October 1, 2020 and on January 30th annually thereafter. 
The joint standing committee may report out legislation based upon the report. 
Sec. 6.  5 MRSA c. 168 is enacted to read: 
CHAPTER 168 
WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM  
§2045.  Authorization 
The Wholesale Prescription Drug Importation Program, referred to in this chapter as 
"the program," is established to provide for the wholesale importation of prescription 
drugs from Canada by or on behalf of the State.  The program must be designed in 
accordance with the requirements of this chapter.  The program may not be implemented 
unless the State obtains approval and certification, pursuant to section 2046, subsection 3, 
from the United States Department of Health and Human Services. 
§2046.  Design of program 
1.  Design requirements.  The Department of Health and Human Services, in 
consultation with appropriate federal and other state agencies, other states and interested 
parties, shall design the program to comply with the applicable requirements of 21 United 
States Code, Section 384, including requirements regarding safety and cost savings.  The 
program design must: 
A.  Designate a state agency to become a licensed drug wholesaler or to contract with 
a licensed drug wholesaler in order to seek federal certification and approval, 
pursuant to subsection 3, to import safe prescription drugs and provide cost savings to 
consumers in the State; 
B.  Use prescription drug suppliers in Canada regulated under the laws of Canada or 
of one or more Canadian provinces, or both; 
C.  Ensure that only prescription drugs meeting the federal Food and Drug 
Administration's safety, effectiveness and other standards are imported by or on 
behalf of the State; 
D.  Import only those prescription drugs expected to generate substantial cost savings 
for consumers in the State; 
E.  Ensure that the program complies with the transaction and tracing requirements of 
United States Code, Sections 360eee and 360eee-1 to the extent feasible and 
practical prior to imported prescription drugs coming into the possession of the 
licensed drug wholesaler and that the program complies fully with those federal 
requirements after imported prescription drugs are in the possession of the licensed 
drug wholesaler; 
F.  Consider whether the program may be developed on a multistate basis through 
collaboration with other states; 
G.  Prohibit the distribution, dispensing or sale of imported prescription drugs outside 
of the State; 
H.  Recommend a charge per prescription or another method of financing to ensure 
that the program is adequately funded in a manner that does not jeopardize significant 
cost savings to consumers, including adequate funding for the initial start-up costs of 
the program; 
I.  Apply for and receive funds, grants or contracts from public and private sources; 
and 
J.  Include an audit function. 
2.  Rules.  The Department of Health and Human Services shall adopt rules to design 
the program in accordance with the requirements of subsection 1 no later than January 1, 
2020. Rules adopted pursuant to this subsection are major substantive rules as defined in 
chapter 375, subchapter 2-A. 
3.  Request for federal approval and certification.  The Department of Health and 
Human Services shall submit a request for approval and certification of the program to 
the United States Department of Health and Human Services no later than May 1, 2020. 
§2047.  Implementation 
1.  Implementation; operation.  Upon receipt of federal approval and certification 
under section 2046, subsection 3, the state agency designated to oversee the program 
pursuant to this chapter shall implement the program as required in subsection 2.  The 
program must begin operating no later than 6 months following receipt of federal 
approval and certification. 
2.  Requirements.  Prior to operating the program, the state agency designated to 
oversee the program pursuant to this chapter shall: 
A.  Become a licensed drug wholesaler or enter into a contract with a licensed drug 
wholesaler in the State; 
B.  Contract with one or more distributors licensed in the State; 
C.  Contract with one or more licensed and regulated prescription drug suppliers in 
Canada; 
D.  Consult with health insurance carriers, employers, pharmacies, pharmacists, 
health care providers and consumers; 
E.  Develop a registration process for health insurance carriers, pharmacies and health 
care providers authorized to prescribe and administer prescription drugs that are 
willing to participate in the program; 
F.  Create a publicly accessible website for listing the prices of prescription drugs to 
be imported under the program; 
G.  Create an outreach and marketing plan to generate public awareness of the 
program; 
H.  Provide a telephone hotline to answer questions and address needs of consumers, 
employers, health insurance carriers, pharmacies, health care providers and others 
affected by the program; 
I.  Develop a 2-year audit work plan; and 
J.  Conduct any other activity determined necessary to successfully implement and 
operate the program. 
§2048.  Annual reporting 
Beginning January 2021, and annually thereafter, the Department of Health and 
Human Services, or other state agency designated to oversee the program pursuant to this 
chapter, shall report to the joint standing committee of the Legislature having jurisdiction 
over health coverage and prescription drugs regarding the implementation and operation 
of the program during the previous calendar year, including: 
1.  Prescription drugs included.  The prescription drugs included in the program; 
2.  Participation.  The number of participating pharmacies, health care providers and 
health insurance carriers; 
3.  Prescriptions dispensed.  The number of prescription drugs dispensed through 
the program; 
4.  Estimated savings.  The estimated cost savings to consumers, health insurance 
carriers, employers and the State during the previous calendar year and to date; 
5.  Audit findings.  Information regarding implementation of the audit work plan and 
audit findings; and 
6.  Other relevant information.  Any other information the Department of Health 
and Human Services, or other state agency designated to oversee the program pursuant to 
this chapter, considers relevant. 
Sec. 7.  5 MRSA §3101, sub-§1, as amended by PL 2019, c. 343, Pt. D, §6 and c. 
383, §1, is repealed and the following enacted in its place: 
1.  Director.  "Director" means the Director of the Office of Policy Innovation and 
the Future established by section 3102. 
Sec. 8.  5 MRSA §3101, sub-§2, as amended by PL 2019, c. 343, Pt. D, §6 and c. 
383, §1, is repealed and the following enacted in its place: 
2.  Office.  "Office" means the Office of Policy Innovation and the Future established 
by section 3102. 
Sec. 9.  5 MRSA §3102, as amended by PL 2019, c. 343, Pt. D, §7 and repealed 
and replaced by c. 383, §2, is repealed and the following enacted in its place: 
§3102.  Office established; purpose 
The Office of Policy Innovation and the Future is established in the Executive 
Department to: support the creation of a coherent system of policy planning and 
coordinated implementation as one function and responsibility of the executive branch; 
serve the Governor as a research, advisory, consultative, coordinating and administrative 
agency; and advance policies that support a sustainable future for the State's people, 
communities, natural resources, physical infrastructure, industries, businesses and 
institutions by: 
1.  Assistance; data; policy.  Providing technical assistance and data to the Governor 
by undertaking special studies and plans as directed and preparing policy; 
2.  Coordination.  Facilitating general intergovernmental coordination; 
3.  Innovation.  Supporting state efforts to encourage innovation and policy that 
facilitates innovation in the public and private sectors; 
4.  Technology.  Supporting improved technology use for government programs and 
advancing responsible state data policies; 
5.  Resources.  Supporting the development of the State's economy and energy 
resources with the conservation of its natural resources; and 
6.  Analysis.  Conducting ongoing demographic, economic, workforce and other 
needed analyses to support state policy makers. 
Sec. 10.  5 MRSA §3103, as amended by PL 2019, c. 343, Pt. D, §8 and c. 383, §3, 
is repealed and the following enacted in its place: 
§3103.  Director 
The Director of the Office of Policy Innovation and the Future is appointed by the 
Governor and serves at the pleasure of the Governor. 
Sec. 11.  5 MRSA §12004-C, sub-§7, as enacted by PL 1995, c. 676, §1 and 
affected by §13, is amended to read: 
7.   
Sec. 12.  5 MRSA §13056, sub-§3, as amended by PL 2019, c. 343, Pt. D, §9 and 
Pt. IIII, §4, is repealed and the following enacted in its place: 
3.  Conduct planning and research.  Conduct planning, research and analysis for 
department needs, but not macroeconomic forecasting, which is the responsibility of the 
Department of Administrative and Financial Services.  The department shall gather and 
maintain and must have access to all economic and other information necessary to the 
performance of its duties; 
Sec. 13.  5 MRSA §13056, sub-§6, ¶B, as amended by PL 2003, c. 159, §2, is 
further amended to read: 
B.  Other community planning and development assistance programs of the former 
State Planning Office; 
Sec. 14.  9-A MRSA §14-105, sub-§5, as enacted by PL 2019, c. 431, §2 and 
affected by §4, is repealed. 
Sec. 15.  10 MRSA §363, sub-§2-A, as amended by PL 2019, c. 343, Pt. D, §11 
and Pt. IIII, §5, is repealed and the following enacted in its place: 
2-A.  Recommendation of Governor and issuers.  At any time action of the 
Legislature under subsection 1-A is necessary or desirable, the Governor shall 
recommend to the appropriate committee of the Legislature a proposed allocation or 
reallocation of all or part of the state ceiling.  To assist the Governor in making a 
recommendation of proposed allocations of the state ceiling on private activity bonds, the 
group of 7 representatives described in subsection 1-A shall make a recommendation 
regarding allocation or reallocation of the state ceiling.  In order to assist the group in 
making its recommendation and to assist the Governor and the Legislature, the 
Department of Administrative and Financial Services shall prepare an annual analysis of 
the State's economic outlook, prevailing interest rate forecasts related to tax-exempt 
financing by the issuers specifically identified in subsections 4 to 8, the availability to 
those issuers of alternative financing from sources that do not require an allocation of the 
state ceiling and the relationship of these factors and various public policy considerations 
School Board of the Maine 
Educational Center for the 
Deaf and Hard of Hearing and 
the Governor Baxter School for 
the Deaf 
Legislative Per Diem 
and Expenses 
20-A MRSA §7406 
to the allocation or reallocation of the state ceiling.  In recommending any allocation or 
reallocation of the state ceiling to the Legislature, the Governor shall consider the 
requests and recommendations of those issuers of bonds within the State designated in 
this section, the recommendations of the group of representatives described in subsection 
1-A and the annual analysis of the Department of Administrative and Financial Services. 
Sec. 16.  10 MRSA §1310-H, sub-§3, as amended by PL 2019, c. 77, §1 and c. 
407, §2, is repealed and the following enacted in its place: 
3.  Nonliability.  A person may not be held liable for any violation of this section if 
the person shows by a preponderance of the evidence that at the time of the alleged 
violation the person maintained reasonable procedures to ensure compliance with the 
provisions of subsections 1, 2, 2-A and 4. 
Sec. 17.  10 MRSA §9722, sub-§6, ¶G, as amended by PL 2019, c. 391, §4, is 
further amended to read: 
G.  In accordance with section 9723, ensure that training and certification regarding 
the Maine Uniform Building and Energy Code is readily available, affordable and 
accessible to municipal building officials; and 
Sec. 18.  10 MRSA §9722, sub-§6, ¶I, as amended by PL 2019, c. 391, §4, is 
further amended to read: 
I.  Approve methods of energy performance rating for use in generating any 
consumer information labels that may be required in the marketing and sale of 
residential and commercial buildings or units within buildings.; and 
Sec. 19.  10 MRSA §9722, sub-§6, ¶M, as repealed by PL 2019, c. 391, §4 and 
amended by c. 392, §1, is repealed. 
Sec. 20.  10 MRSA §9722, sub-§6, ¶N, as repealed by PL 2019, c. 391, §4 and 
amended by c. 392, §2, is repealed. 
Sec. 21.  12 MRSA §8876, sub-§2, as amended by PL 2019, c. 343, Pt. D, §12 
and Pt. IIII, §6, is repealed and the following enacted in its place: 
2.  Future demand.  Project future demand for forest resources based on a common 
economic forecast developed by the Consensus Economic Forecasting Commission and 
on other appropriate economic projections; 
Sec. 22.  12 MRSA §11154, sub-§2, as amended by PL 2017, c. 427, §11 and 
affected by §19 and amended by c. 458, §1, is repealed and the following enacted in its 
place: 
2.  Issuance of moose hunting permits.  In accordance with section 11552, the 
commissioner may issue moose hunting permits and may establish the number of moose 
hunting permits to be issued for each wildlife management district established by the 
commissioner by rule open to moose hunting.  No more than 8% of the moose hunting 
permits may be issued to nonresident hunters.  No more than 2% of the moose hunting 
permits may be issued to hunting outfitters in accordance with subsection 14. 
Sec. 23.  19-A MRSA §4012, sub-§5, as amended by PL 2019, c. 412, §9, is 
further amended to read: 
5.  Arrest in certain situations.  When a law enforcement officer has probable cause 
to believe that there has been a criminal violation under section 4011 of a court-approved 
consent agreement or a protection order issued pursuant to this chapter or Title 15, 
chapter 12-A, or that a violation of Title 17-A, section 208-D, 208-E, or 208-F has 
occurred, that enforcement officer shall arrest and take into custody the alleged offender. 
Sec. 24.  20-A MRSA §10, sub-§2, ¶G, as amended by PL 2019, c. 450, §12, is 
further amended to read: 
G.  The Maine Municipal Association; and 
Sec. 25.  20-A MRSA §10, sub-§2, ¶H, as amended by PL 2019, c. 450, §13, is 
further amended to read: 
H.  The Maine Principals Association.; and 
Sec. 26.  22 MRSA §2422, sub-§4-N, as enacted by PL 2019, c. 331, §2 and c. 
528, §16, is repealed and the following enacted in its place: 
4-N.  Immature marijuana plant.  "Immature marijuana plant" means a 
nonflowering marijuana plant that measures more than 24 inches from the base of the 
main plant stalk to the most distant point of the plant's leaf stems or branches.  "Immature 
marijuana plant" does not include hemp as defined in Title 7, section 2231, subsection 
1-A, paragraph D. 
Sec. 27.  22 MRSA §2422, sub-§4-S, as enacted by PL 2019, c. 331, §2 and c. 
528, §16, is repealed and the following enacted in its place: 
4-S.  Marijuana concentrate.  "Marijuana concentrate" means the resin extracted 
from any part of a marijuana plant and every compound, manufacture, salt, derivative, 
mixture or preparation from such resin, including, but not limited to, hashish.  "Marijuana 
concentrate" does not include resin extracted from hemp as defined in Title 7, section 
2231, subsection 1-A, paragraph D or any compound, manufacture, salt, derivative, 
mixture or preparation therefrom. 
Sec. 28.  22 MRSA §2428, sub-§1-A, ¶F, as repealed and replaced by PL 2019, 
c. 331, §24 and c. 354, §7, is repealed and the following enacted in its place: 
F.  Except as provided in section 2426: 
(1)  Transfer marijuana plants and harvested marijuana to a qualifying patient and 
to a caregiver on behalf of a qualifying patient in a retail sale for reasonable 
compensation; 
(2)  Transfer marijuana plants and harvested marijuana to a qualifying patient, 
caregiver or dispensary for no remuneration; 
(3)  Acquire marijuana plants and harvested marijuana from another dispensary 
for no remuneration; 
(4)  Transfer to and accept from a registered caregiver or another dispensary 
marijuana plants and harvested marijuana in a wholesale transaction in 
accordance with this paragraph. A dispensary may transfer in wholesale 
transactions for reasonable compensation or for no remuneration up to 75% of the 
mature marijuana plants grown by the dispensary over the course of a calendar 
year, including any marijuana products or marijuana concentrate manufactured 
from that 75% of the mature marijuana plants grown by the dispensary.  A 
dispensary may transfer to or accept from registered caregivers and dispensaries 
in wholesale transactions an unlimited amount of immature marijuana plants and 
seedlings.  A dispensary that acquires mature marijuana plants, marijuana 
products or marijuana concentrate in a wholesale transaction under this 
subparagraph may not resell the mature marijuana plants, marijuana products or 
marijuana concentrate except to a qualifying patient or to a caregiver or 
dispensary to assist a qualifying patient; 
(5)  Transfer harvested marijuana to a manufacturing facility and accept 
marijuana products and marijuana concentrate from the manufacturing facility 
that are produced from the harvested marijuana the dispensary provided to the 
manufacturing facility; and 
(6)  Provide samples to a marijuana testing facility for testing and research 
purposes; 
Sec. 29.  22 MRSA §3739, sub-§2, ¶G, as repealed by PL 2019, c. 450, §16 and 
amended by c. 524, §16, is repealed. 
Sec. 30.  24-A MRSA §4316, sub-§4, ¶C, as enacted by PL 2019, c. 289, §2, is 
amended to read: 
C.  The enrollee is cognitively and physically capable of operating the mobile health 
devices or the enrollee has a caregiver willing and able to assist with the mobile 
health devices; and 
Sec. 31.  25 MRSA §1542-A, sub-§1, ¶R, as amended by PL 2019, c. 343, Pt. G, 
§5; c. 399, §3; c. 402, §3; and c. 416, §3, is repealed and the following enacted in its 
place: 
R.  Who is required to have a criminal background check under Title 22, section 
8302-A or 8302-B; 
Sec. 32.  25 MRSA §1542-A, sub-§1, ¶S, as enacted by PL 2019, c. 399, §4 and 
c. 402, §4 and reallocated by c. 343, Pt. G, §4 and c. 416, §2, is repealed and the 
following enacted in its place: 
S.  Who is required to have a criminal history record check under Title 22, section 
2425-A, subsection 3-A; 
Sec. 33.  25 MRSA §1542-A, sub-§1, ¶T, as enacted by PL 2019, c. 399, §4; c. 
402, §4; and c. 416, §4, is repealed and the following enacted in its place: 
T.  Who is required to have a criminal history record check under Title 22, section 
8110; 
Sec. 34.  25 MRSA §1542-A, sub-§1, ¶U is enacted to read: 
U.  Who is required to have a criminal history record check under Title 19-A, section 
2111; 
Sec. 35.  25 MRSA §1542-A, sub-§1, ¶V is enacted to read: 
V.  Who is employed or may be offered employment by the Office of the State 
Auditor as required under Title 5, section 247. 
Sec. 36.  25 MRSA §1542-A, sub-§3, ¶O, as repealed by PL 2019, c. 343, Pt. G, 
§8 and c. 416, §5, and repealed and replaced by c. 399, §5 and c. 402, §5, is repealed and 
the following enacted in its place: 
O.  The State Police shall take or cause to be taken the fingerprints of the person 
named in subsection 1, paragraph P at the request of that person and upon payment of 
the expenses by that person as required by Title 32, section 2571-A. 
Sec. 37.  25 MRSA §1542-A, sub-§3, ¶S, as enacted by PL 2019, c. 399, §6; c. 
402, §6; and c. 416, §7, is repealed and the following enacted in its place: 
S.  The State Police shall take or cause to be taken the fingerprints of the person 
named in subsection 1, paragraph T at the request of that person or the Department of 
Health and Human Services pursuant to Title 22, section 8110. 
Sec. 38.  25 MRSA §1542-A, sub-§3, ¶T is enacted to read: 
T.  The State Police shall take or cause to be taken the fingerprints of the person 
named in subsection 1, paragraph U at the request of that person or the Department of 
Health and Human Services pursuant to Title 19-A, section 2111. 
Sec. 39.  25 MRSA §1542-A, sub-§3, ¶U is enacted to read: 
U.  The State Police shall take or cause to be taken the fingerprints of the person 
named in subsection 1, paragraph V at the request of that person or the Office of the 
State Auditor and upon payment by the Office of the State Auditor of the fee 
established in Title 5, section 247, subsection 3. 
Sec. 40.  25 MRSA §1542-A, sub-§4, as repealed and replaced by PL 2019, c. 
343, Pt. G, §10; c. 399, §7; c. 402, §7; and c. 416, §8, is repealed and the following 
enacted in its place: 
4.  Duty to submit to State Bureau of Identification.  It is the duty of the law 
enforcement agency taking the fingerprints as required by subsection 3, paragraphs A, B 
and G to transmit immediately to the State Bureau of Identification the criminal 
fingerprint record. Fingerprints taken pursuant to subsection 1, paragraph C, D, E or F or 
pursuant to subsection 5 may not be submitted to the State Bureau of Identification unless 
an express request is made by the commanding officer of the State Bureau of 
Identification.  Fingerprints taken pursuant to subsection 1, paragraph G must be 
transmitted immediately to the State Bureau of Identification to enable the bureau to 
conduct state and national criminal history record checks for the Department of 
Education.  The bureau may not use the fingerprints for any purpose other than that 
provided for under Title 20-A, section 6103.  The bureau shall retain the fingerprints, 
except as provided under Title 20-A, section 6103, subsection 9.  Fingerprints taken 
pursuant to subsection 1, paragraph I and subsection 3, paragraph I must be transmitted 
immediately to the State Bureau of Identification to enable the bureau to conduct state 
and national criminal history record checks for the court and the Department of Public 
Safety, Gambling Control Board, respectively.  Fingerprints taken pursuant to subsection 
1, paragraph J or S must be transmitted immediately to the State Bureau of Identification 
to enable the bureau to conduct state and national criminal history record checks for the 
Department of Administrative and Financial Services.  Fingerprints taken pursuant to 
subsection 1, paragraph P must be transmitted immediately to the State Bureau of 
Identification to enable the bureau to conduct state and national criminal history record 
checks for the Board of Osteopathic Licensure, established in Title 32, chapter 36.  
Fingerprints taken pursuant to subsection 1, paragraph N must be transmitted 
immediately to the State Bureau of Identification to enable the bureau to conduct state 
and national criminal history record checks for the Board of Licensure in Medicine, 
established in Title 32, chapter 48.  Fingerprints taken pursuant to subsection 1, paragraph 
Q must be transmitted immediately to the State Bureau of Identification to enable the 
bureau to conduct state and national criminal history record checks for the State Board of 
Nursing, established in Title 32, chapter 31.  Fingerprints taken pursuant to subsection 1, 
paragraph O must be transmitted immediately to the State Bureau of Identification to 
enable the bureau to conduct state and national criminal history record checks under Title 
28-B, section 204.  Fingerprints taken pursuant to subsection 1, paragraph R, T or U must 
be transmitted immediately to the State Bureau of Identification to enable the bureau to 
conduct state and national criminal history record checks for the Department of Health 
and Human Services.  Fingerprints taken pursuant to subsection 1, paragraph V must be 
transmitted immediately to the State Bureau of Identification to enable the bureau to 
conduct state and national criminal history record checks for the Office of the State 
Auditor. 
Sec. 41.  26 MRSA §3, sub-§3, ¶B, as amended by PL 2019, c. 343, Pt. D, §13 
and Pt. IIII, §7, is repealed and the following enacted in its place: 
B.  Information and records pertaining to the workforce, employment patterns, wage 
rates, poverty and low-income patterns, economically distressed communities and 
regions and other similar information and data to the Department of Administrative 
and Financial Services and the Department of Economic and Community 
Development for the purposes of analysis and evaluation, measuring and monitoring 
poverty and economic and social conditions throughout the State, and promoting 
economic development. 
Sec. 42.  30-A MRSA §4312, sub-§3, ¶K, as amended by PL 2019, c. 38, §3; c. 
145, §3; and c. 153, §2, is further amended to read: 
K.  To encourage municipalities to develop policies that assess community needs and 
environmental effects of municipal regulations, lessen the effect of excessive parking 
requirements for buildings in downtowns and on main streets and provide for 
alternative approaches for compliance relating to the reuse of upper floors of 
buildings in downtowns and on main streets; and 
Sec. 43.  30-A MRSA §4312, sub-§3, ¶M, as enacted by PL 2019, c. 145, §4 and 
reallocated by RR 2019, c. 1, Pt. A, §38, is amended to read: 
M.  To encourage municipalities to develop policies that provide for accessory 
dwelling units.; and 
Sec. 44.  30-A MRSA §5903, sub-§6-A, as amended by PL 2019, c. 343, Pt. D, 
§14 and Pt. IIII, §9, is repealed and the following enacted in its place: 
6-A.  Median household income.  "Median household income" means the income 
computed based on the most current census information available, as provided by the 
State Economist. 
Sec. 45.  35-A MRSA §3454, first ¶, as amended by PL 2019, c. 343, Pt. D, §15 
and Pt. IIII, §10, is repealed and the following enacted in its place: 
In making findings pursuant to Title 38, section 484, subsection 3, the primary siting 
authority shall presume that an expedited wind energy development provides energy and 
emissions-related benefits described in section 3402 and shall make additional findings 
regarding other tangible benefits provided by the development.  The Department of 
Labor, the Governor's Energy Office and the Public Utilities Commission shall provide 
review comments if requested by the primary siting authority. 
Sec. 46.  35-A MRSA §10104, sub-§4, ¶F, as amended by PL 2019, c. 313, §5 
and c. 476, §4, is repealed and the following enacted in its place: 
F.  It is an objective of the triennial plan to design, coordinate and integrate sustained 
energy efficiency and weatherization programs that are available to all energy 
consumers in the State and to users of all fuel types.  The plan must set forth the costs 
and benefits of energy efficiency programs that advance the following goals and 
funding necessary to meet those goals: 
(1)  Reducing energy costs, including residential heating costs; 
(2)  Weatherizing substantially all homes whose owners or occupants are willing 
to participate in and share the costs of cost-effective home weatherization to a 
minimum standard of weatherization, as defined by the trust, by 2030; 
(3)  Reducing peak-load demand for electricity through trust programs by 300 
megawatts by 2020; 
(4)  By 2020, achieving electricity and natural gas program savings of at least 
20% and heating fuel savings of at least 20%, as defined in and determined 
pursuant to the performance metrics approved by the commission under section 
10120; 
(5)  Creating stable private sector jobs providing alternative energy and energy 
efficiency products and services in the State by 2020; and 
(6)  Contributing to the effort to reduce greenhouse gas emissions in the State by 
amounts consistent with the greenhouse gas emission levels established in Title 
38, section 576-A. 
As used in this paragraph, "heating fuel" means liquefied petroleum gas, kerosene or 
#2 heating oil, but does not include fuels when used for industrial or manufacturing 
processes. 
Sec. 47.  35-A MRSA §10104, sub-§4, ¶G, as enacted by PL 2019, c. 298, §21 
and c. 313, §5, is repealed and the following enacted in its place: 
G.  In developing the triennial plan, or an annual update plan under subsection 6, the 
trust may include, as part of its budget for electric efficiency and conservation 
programs under section 10110, the costs of providing nonwires alternatives in 
accordance with section 3132-D. 
Sec. 48.  35-A MRSA §10104, sub-§4, ¶H is enacted to read: 
H.  After the triennial plan is approved, the trust or any party to the triennial plan may 
petition for, or the commission may initiate on its own, consideration of revising the 
calculations of avoided energy costs used in the determination of maximum 
achievable cost-effective energy efficiency resources pursuant to section 10110, 
subsection 4-A or section 10111, subsection 2 upon a showing that, subsequent to the 
publication of the avoided energy cost study relied upon, changes in price forecasts 
would result in more than a 25% change in the value of avoided energy cost affecting 
a significant portion of the program activity in the triennial plan. 
Sec. 49.  35-A MRSA §10110, sub-§1, ¶C, as amended by PL 2019, c. 306, §4 
and c. 365, §2, is repealed and the following enacted in its place: 
C.  "Conservation programs" means programs developed by the trust pursuant to this 
section designed to increase the efficiency of electricity use. 
Sec. 50.  36 MRSA §1754-B, sub-§1-B, as enacted by PL 2019, c. 401, Pt. B, 
§11 and c. 441, §4, is repealed and the following enacted in its place: 
1-B.  Persons required to register.  Except as otherwise provided in this section and 
section 1951-C, the following persons, other than casual sellers, shall register with the 
assessor and collect and remit taxes in accordance with the provisions of this Part: 
A.  Every person that has a substantial physical presence in this State and that makes 
sales of tangible personal property or taxable services in this State, including, but not 
limited to: 
(1)  Every person that makes sales of tangible personal property or taxable 
services, whether or not at retail, that maintains in this State any office, 
manufacturing facility, distribution facility, warehouse or storage facility, sales or 
sample room or other place of business; 
(2)  Every person that makes sales of tangible personal property or taxable 
services that does not maintain a place of business in this State but makes retail 
sales in this State or solicits orders, by means of one or more salespeople within 
this State, for retail sales within this State; and 
(3)  Every lessor engaged in the leasing of tangible personal property located in 
this State that does not maintain a place of business in this State but makes retail 
sales to purchasers from this State; 
B.  Every person that makes sales of tangible personal property or taxable services for 
delivery into this State if: 
(1)  The person's gross sales from delivery of tangible personal property or 
taxable services into this State in the previous calendar year or current calendar 
year exceeds $100,000; or 
(2)  The person sold tangible personal property or taxable services for delivery 
into this State in at least 200 separate transactions in the previous calendar year or 
the current calendar year; 
C.  Every person that has a substantial physical presence in this State and that makes 
retail sales in this State of tangible personal property or taxable services on behalf of 
a principal that is outside of this State if the principal is not the holder of a valid 
registration certificate; 
D.  Every agent, representative, salesperson, solicitor or distributor that has a 
substantial physical presence in this State and that receives compensation by reason 
of sales of tangible personal property or taxable services made outside this State by a 
principal for use, storage or other consumption in this State; 
E.  Every person that manages or operates in the regular course of business or on a 
casual basis a hotel, rooming house or tourist or trailer camp in this State or that 
collects or receives rents on behalf of a hotel, rooming house or tourist or trailer camp 
in this State; 
F.  Every person that operates a transient rental platform and reserves, arranges for, 
offers, furnishes or collects or receives consideration for the rental of living quarters 
in this State; 
G.  Every room remarketer; 
H.  Every person that makes retail sales in this State of tangible personal property or 
taxable services on behalf of the owner of that property or the provider of those 
services; 
I.  Every person not otherwise required to be registered that sells tangible personal 
property to the State and is required to register as a condition of doing business with 
the State pursuant to Title 5, section 1825-B; 
J.  Every person that holds a wine direct shipper license under Title 28-A, section 
1403-A; and 
K.  A marketplace facilitator if: 
(1)  The marketplace facilitator's gross sales from delivery of tangible personal 
property or taxable services into this State in the previous calendar year or 
current calendar year exceeds $100,000; or 
(2)  The marketplace facilitator sold or facilitated sales of tangible personal 
property or taxable services for delivery into this State in at least 200 separate 
transactions in the previous calendar year or the current calendar year. 
For the purposes of this paragraph, the marketplace facilitator's gross sales and total 
number of transactions include sales facilitated on behalf of marketplace sellers and 
any sales of tangible personal property or taxable services made directly by the 
marketplace facilitator. 
Sec. 51.  36 MRSA §1817, sub-§5, as repealed by PL 2017, c. 409, Pt. D, §3 and 
amended by c. 452, §30, is repealed. 
Sec. 52.  37-B MRSA §111, as enacted by PL 1983, c. 460, §3, is repealed. 
Sec. 53.  38 MRSA §484, sub-§10, as amended by PL 2019, c. 343, Pt. D, §17 
and Pt. IIII, §12, is repealed and the following enacted in its place: 
10.  Special provisions; wind energy development or offshore wind power 
project.  In the case of a grid-scale wind energy development, or an offshore wind power 
project with an aggregate generating capacity of 3 megawatts or more, the proposed 
generating facilities, as defined in Title 35-A, section 3451, subsection 5: 
A.  Will be designed and sited to avoid unreasonable adverse shadow flicker effects; 
B.  Will be constructed with setbacks adequate to protect public safety.  In making a 
finding pursuant to this paragraph, the department shall consider the recommendation 
of a professional, licensed civil engineer as well as any applicable setback 
recommended by a manufacturer of the generating facilities; and 
C.  Will provide significant tangible benefits as determined pursuant to Title 35-A, 
section 3454, if the development is an expedited wind energy development. 
The Department of Labor, the Governor's Energy Office and the Public Utilities 
Commission shall provide review comments if requested by the primary siting authority. 
For purposes of this subsection, "grid-scale wind energy development," "primary siting 
authority," "significant tangible benefits" and "expedited wind energy development" have 
the same meanings as in Title 35-A, section 3451. 
Sec. 54.  PL 2019, c. 343, Pt. D, §18 is amended to read: 
Sec. D-18.  Maine Revised Statutes amended; revision clause.  Wherever in 
the Maine Revised Statutes the words "Governor's Office of Policy and Management" 
appear or reference is made to that entity or those words, those words are amended to 
read or mean, as appropriate, "Governor's Office of Policy Innovation and the Future" 
and the Revisor of Statutes shall implement this revision when updating, publishing or 
republishing the statutes. 
Sec. 55.  PL 2019, c. 477, §3 is amended to read: 
Sec. 3.  Study; report; renewable energy goals market assessment.  The 
Governor's Office of Policy Innovation and Management the Future and the Governor's 
Energy Office shall jointly conduct a market assessment study, including an in-depth 
analysis and review of the opportunities, potential and challenges facing the State in 
reaching the goal by January 1, 2030 that 80% of retail electricity sales in this State will 
come from renewable energy resources, and shall, no later than January 31, 2021, submit 
a report on the market assessment study, along with any recommendations on adjustments 
or changes to the renewable portfolio requirements in the Maine Revised Statutes, Title 
35-A, section 3210, to the joint standing committee of the Legislature having jurisdiction 
over energy and utilities matters. 
1.  The market assessment study must include, but is not limited to, examination of: 
A.  The availability of commercially viable renewable energy technologies, including 
emerging technologies, in the State and region between 2020 and 2030; 
B.  The estimated electricity costs and benefits for ratepayers and the capacity of 
commercially viable renewable energy technologies during the 10-year period 
between 2020 and 2030, including the remaining useful lives of existing technology 
in use during that period; 
C.  The time frames for permitting, financing and construction for commercially 
viable renewable technologies in the State and region; 
D.  The policy and regulatory options and structures that may influence the speed, 
predictability and cost to ratepayers associated with the development of renewable 
energy technologies in this State and the amount of renewable energy generated; 
E.  Policies and regulations in other states and the region, including an analysis of the 
dynamics between and among the various states, provinces and this State, and the 
importance and role of generating 80% of electricity from renewable capacity 
resources in achieving the greenhouse reduction limits in Title 38, chapter 3-A in a 
cost-effective manner; and 
F.  In coordination with the Department of Environmental Protection, the benefits and 
costs of incentives provided to generators fueled by municipal solid waste, landfill 
gas facilities and anaerobic digestion facilities under the State's renewable portfolio 
requirements.  The examination must also consider and make recommendations for 
further alignment between renewable energy and solid waste policy initiatives. 
2.  Upon written request of the Governor's Office of Policy Innovation and 
Management the Future or the Governor's Energy Office, the Public Utilities Commission 
shall provide for the study: 
A.  Reasonable technical, legal and other assistance, including the provision of 
requested information; and 
B.  Funding for staff and consultants in an amount not to exceed $150,000. Any such 
costs must be recovered through assessments on transmission and distribution utilities 
in accordance with Title 35-A, section 116. 
3.  The Governor's Office of Policy Innovation and Management the Future and the 
Governor's Energy Office shall encourage state agencies, including the Office of the 
Public Advocate, and other interested parties to submit relevant information, including 
data, to inform the market assessment study.  Not more than 60 days prior to issuance of 
the report required by this section, the offices shall invite interested parties to provide 
comments on draft proposed conclusions of the study. 
Sec. 56.  Resolve 2019, c. 82, §5 is amended to read: 
Sec. 5.  Duties.  Resolved:  That the committee shall examine and make 
recommendations on the feasibility of providing basic economic security through a direct 
cash payment system and other programs that are designed to help individuals and 
families become more economically secure, including, but not limited to: 
1.  Tax rebates and credits, including strengthening the earned income tax credit and 
a negative income tax; 
2.  Universal basic income and unconditional cash transfers to residents of the State; 
and 
3.  Other direct cash benefit programs. 
The committee shall also investigate the effectiveness of existing safety net 
programs, such as tax credit, child care and food supplement programs, and compare 
those programs to any recommended direct cash payment programs. 
In fulfilling its duties under this section, the committee shall as necessary invite input 
from the Department of Administrative and Financial Services, Bureau of Revenue 
Services and from the Governor's Office of Policy Innovation and Management the 
Future. 
Emergency clause.  In view of the emergency cited in the preamble, this 
legislation takes effect when approved. 
SUMMARY 
Section 1 corrects a conflict created by Public Law 2019, chapters 59 and 475, which 
affected the same provision of law, by incorporating the changes made by both laws and 
using the chapter 475 version of the reference to the Chief Justice of the Supreme Judicial 
Court. 
Sections 2 to 4 correct a conflict created by Public Law 2019, chapter 343, Part D and 
Part IIII, which affected the same provisions of law, by repealing the provisions and 
replacing them with the Part IIII versions. 
Sections 5 and 6 correct a numbering problem created by Public Law 2019, chapters 
and 472, which enacted 2 substantively different provisions with the same chapter 
number in the Maine Revised Statutes, Title 5.  These sections correct the conflict by 
repealing Title 5, chapter 167 and replacing it with the chapter 471 version and enacting 
the chapter 472 version as Title 5, chapter 168. 
Sections 7 and 8 correct conflicts created by Public Law 2019, chapters 343 and 383, 
which affected the same provisions of law, by repealing the provisions and replacing 
them with the chapter 383 versions. 
Section 9 corrects a conflict created by Public Law 2019, chapters 343 and 383, 
which affected the same provision of law, by repealing the provision and replacing it with 
the chapter 383 version and corrects a clerical error. 
Section 10 corrects a conflict created by Public Law 2019, chapters 343 and 383, 
which affected the same provision of law, by repealing the provision and replacing it with 
the chapter 383 version. 
Section 11 corrects a reference to the Maine Educational Center for the Deaf and 
Hard of Hearing and the Governor Baxter School for the Deaf. 
Section 12 corrects a conflict created by Public Law 2019, chapter 343, Part D and 
Part IIII, which affected the same provision of law, by repealing the provision and 
replacing it with the Part IIII version. 
Section 13 corrects a reference to the former State Planning Office. 
Section 14 repeals duplicate language. 
Section 15 corrects a conflict created by Public Law 2019, chapter 343, Part D and 
Part IIII, which affected the same provision of law, by repealing the provision and 
replacing it with the Part IIII version. 
Section 16 corrects a conflict created by Public Law 2019, chapters 77 and 407, 
which affected the same provision of law, by incorporating the changes made by both 
laws. 
Section 17 makes a technical correction. 
Section 18 makes a technical correction. 
Section 19 corrects a conflict created when Public Law 2019, chapter 391 repealed 
Title 10, section 9722, subsection 6, paragraph M and Public Law 2019, chapter 392 
amended the paragraph.  This section corrects the conflict by repealing the paragraph. 
Section 20 corrects a conflict created when Public Law 2019, chapter 391 repealed 
Title 10, section 9722, subsection 6, paragraph N and Public Law 2019, chapter 392 
amended the paragraph.  This section corrects the conflict by repealing the paragraph. 
Section 21 corrects a conflict created by Public Law 2019, chapter 343, Part D and 
Part IIII, which affected the same provision of law, by repealing the provision and 
replacing it with the Part IIII version. 
Section 22 corrects a conflict created by Public Law 2017, chapters 427 and 458, 
which affected the same provision of law, by incorporating the changes made by both 
laws. 
Section 23 corrects a clerical error. 
Sections 24 and 25 make technical corrections. 
Section 26 corrects a conflict created by Public Law 2019, chapters 331 and 528, 
which affected the same provision of law, by incorporating the changes made by both 
laws. 
Section 27 corrects a conflict created by Public Law 2019, chapters 331 and 528, 
which affected the same provision of law, by incorporating the changes made by both 
laws. 
Section 28 corrects a conflict created by Public Law 2019, chapters 331 and 354, 
which affected the same provision of law, by repealing the provision and replacing it with 
the chapter 354 version. 
Section 29 corrects a conflict created by Public Law 2019, chapter 450, which 
repealed Title 22, section 3739, and Public Law 2019, chapter 524, which amended 
section 3739, subsection 2, paragraph G, by repealing paragraph G. 
Section 30 corrects a clerical error. 
Section 31 corrects a conflict created by Public Law 2019, chapters 343, 399, 402 and 
416, which affected the same provision of law, by repealing the provision and replacing it 
with the chapters 399 and 402 version. 
Section 32 corrects a conflict created by Public Law 2019, chapters 343, 399, 402 and 
416, which affected the same provision of law, by repealing the provision and replacing it 
with the chapters 399 and 402 version and making a technical correction. 
Sections 33 to 35 correct a lettering problem created by Public Law 2019, chapters 
399, 402 and 416, which enacted 3 substantively different provisions with the same 
paragraph letter, and make technical changes. 
Section 36 corrects a conflict created by Public Law 2019, chapters 343, 399, 402 and 
416, which affected the same provision of law, by repealing the provision and replacing it 
with the chapters 399 and 402 version. 
Sections 37 to 39 correct a lettering problem created by Public Law 2019, chapters 
399, 402 and 416, which enacted 3 substantively different provisions with the same 
paragraph letter, and correct cross-references. 
Section 40 corrects a conflict created by Public Law 2019, chapters 343, 399, 402 and 
416, which affected the same provision of law, by repealing the provision and replacing it 
with a version incorporating the changes made by all 4 laws. 
Section 41 corrects a conflict created by Public Law 2019, chapter 343, Parts D and 
IIII, which affected the same provision of law, by repealing the provision and replacing it 
with the Part IIII version. 
Sections 42 and 43 make technical corrections. 
Section 44 corrects a conflict created by Public Law 2019, chapter 343, Parts D and 
IIII, which affected the same provision of law, by repealing the provision and replacing it 
with the Part IIII version. 
Section 45 corrects a conflict created by Public Law 2019, chapter 343, Parts D and 
IIII, which affected the same provision of law, by repealing the provision and replacing it 
with the Part IIII version. 
Section 46 corrects a conflict created by Public Law 2019, chapters 313 and 476, 
which affected the same provision of law, by repealing the provision and replacing it with 
the chapter 313 version and corrects a cross-reference. 
Sections 47 and 48 correct a lettering problem created by Public Law 2019, chapters 
and 313, which enacted 2 substantively different provisions with the same paragraph 
letter. 
Section 49 corrects a conflict created by Public Law 2019, chapters 306 and 365, 
which affected the same provision of law, by repealing the provision and replacing it with 
the chapter 306 version. 
Section 50 corrects a conflict created by Public Law 2019, chapters 401 and 441, 
which affected the same provision of law, by repealing the provision and replacing it with 
the chapter 441 version. 
Section 51 corrects a conflict created when Public Law 2017, chapter 409 repealed 
Title 36, section 1817, subsection 5 and Public Law 2017, chapter 452 amended the 
subsection.  This section corrects the conflict by repealing the subsection. 
Section 52 repeals an outdated provision regarding gender. 
Section 53 corrects a conflict created by Public Law 2019, chapter 343, Parts D and 
IIII, which affected the same provision of law, by repealing the provision and replacing it 
with the Part IIII version. 
Section 54 corrects a revision clause. 
Section 55 corrects provisions to implement the intent of the revision clauses 
contained in Public Law 2019, chapter 343, Part D, section 18 and chapter 383, section 
10. 
Section 56 corrects provisions to implement the intent of the revision clauses 
contained in Public Law 2019, chapter 343, Part D, section 18 and chapter 383, section 
10.